You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11. Distribution of clients entering treatment according to age at first use of primary drug and primary drug - EU overall summary in 2005 [see all tables in this series...]

Part (viii) Distribution of all inpatient clients by primary drug for each age group

Substance	<15	15-19	20-24	25-29	30-34	35-39	40-44	45+	Age known	Age not known
Opiates	13.7	32.0	49.7	48.6	48.9	44.0	33.3	20.8	9952	1227
Cocaine	4.0	10.9	13.1	13.7	12.4	9.7	6.2	2.4	2955	394
Stimulants	18.7	24.0	14.1	11.6	10.1	9.6	4.7	1.7	5337	496
Hypnotics and sedatives	3.6	4.5	8.8	13.9	17.7	26.6	42.1	60.1	2405	429
Hallucinogens	3.4	6.0	3.6	2.4	0.9	1.2	0.0	0.4	1242	120
Volatile substances	5.1	1.7	0.9	0.5	0.3	0.2	0.3	0.0	526	27
Cannabis	47.2	19.4	8.3	7.0	6.0	5.6	6.5	2.6	5496	627
Other substances	4.2	1.6	1.6	2.4	3.8	3.1	7.0	11.9	691	1091
Total	4472	13473	5561	2441	1223	586	387	461	28604	4411

Notes:

Countries reporting data: BG, CZ, DK, DE, IE, EL, CY, LU, RO, SK, FI, SE, TR

The number of treatment clients in each country is listed in [Table TDI-7].

See also 'TDI-109-All inpatient age at first use and primary drug.xls' on distribution by country and 'General notes for interpreting data' on the Explanatory notes and help page.

Sources:

2006 Reitox national reports - Table TDI inpatient treatment centres.